Literature DB >> 26537686

Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.

Carolien E van de Sandt1, Joost H C M Kreijtz1, Martina M Geelhoed-Mieras1, Nella J Nieuwkoop1, Monique I Spronken1, David A M C van de Vijver1, Ron A M Fouchier1, Albert D M E Osterhaus2, Guus F Rimmelzwaan3.   

Abstract

UNLABELLED: Natural influenza A virus infections elicit both virus-specific antibody and CD4(+) and CD8(+) T cell responses. Influenza A virus-specific CD8(+) cytotoxic T lymphocytes (CTLs) contribute to clearance of influenza virus infections. Viral CTL epitopes can display variation, allowing influenza A viruses to evade recognition by epitope-specific CTLs. Due to functional constraints, some epitopes, like the immunodominant HLA-A*0201-restricted matrix protein 1 (M158-66) epitope, are highly conserved between influenza A viruses regardless of their subtype or host species of origin. We hypothesized that human influenza A viruses evade recognition of this epitope by impairing antigen processing and presentation by extraepitopic amino acid substitutions. Activation of specific T cells was used as an indication of antigen presentation. Here, we show that the M158-66 epitope in the M1 protein derived from human influenza A virus was poorly recognized compared to the M1 protein derived from avian influenza A virus. Furthermore, we demonstrate that naturally occurring variations at extraepitopic amino acid residues affect CD8(+) T cell recognition of the M158-66 epitope. These data indicate that human influenza A viruses can impair recognition by M158-66-specific CTLs while retaining the conserved amino acid sequence of the epitope, which may represent a yet-unknown immune evasion strategy for influenza A viruses. This difference in recognition may have implications for the viral replication kinetics in HLA-A*0201 individuals and spread of influenza A viruses in the human population. The findings may aid the rational design of universal influenza vaccines that aim at the induction of cross-reactive virus-specific CTL responses. IMPORTANCE: Influenza viruses are an important cause of acute respiratory tract infections. Natural influenza A virus infections elicit both humoral and cellular immunity. CD8(+) cytotoxic T lymphocytes (CTLs) are directed predominantly against conserved internal proteins and confer cross-protection, even against influenza A viruses of various subtypes. In some CTL epitopes, mutations occur that allow influenza A viruses to evade recognition by CTLs. However, the immunodominant HLA-A*0201-restricted M158-66 epitope does not tolerate mutations without loss of viral fitness. Here, we describe naturally occurring variations in amino acid residues outside the M158-66 epitope that influence the recognition of the epitope. These results provide novel insights into the epidemiology of influenza A viruses and their pathogenicity and may aid rational design of vaccines that aim at the induction of CTL responses.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26537686      PMCID: PMC4702701          DOI: 10.1128/JVI.02439-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Mechanisms of MHC class I-restricted antigen presentation.

Authors:  Matthias Hofmann; Alexander K Nussbaum; Niels PN Emmerich; Lars Stoltze; Hansjörg Schild
Journal:  Expert Opin Ther Targets       Date:  2001-06       Impact factor: 6.902

3.  Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.

Authors:  E G M Berkhoff; M M Geelhoed-Mieras; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Gen Virol       Date:  2007-02       Impact factor: 3.891

4.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.

Authors:  M Del Val; H J Schlicht; T Ruppert; M J Reddehase; U H Koszinowski
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

Review 5.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

6.  The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication.

Authors:  Shuai Cao; Xiaoling Liu; Maorong Yu; Jing Li; Xiaojuan Jia; Yuhai Bi; Lei Sun; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

8.  Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells.

Authors:  Zhongfang Wang; Yanmin Wan; Chenli Qiu; Sergio Quiñones-Parra; Zhaoqin Zhu; Liyen Loh; Di Tian; Yanqin Ren; Yunwen Hu; Xiaoyan Zhang; Paul G Thomas; Michael Inouye; Peter C Doherty; Katherine Kedzierska; Jianqing Xu
Journal:  Nat Commun       Date:  2015-05-13       Impact factor: 14.919

9.  Hepatitis C virus mutation affects proteasomal epitope processing.

Authors:  Ulrike Seifert; Heike Liermann; Vito Racanelli; Anne Halenius; Manfred Wiese; Heiner Wedemeyer; Thomas Ruppert; Kay Rispeter; Peter Henklein; Alice Sijts; Hartmut Hengel; Peter-M Kloetzel; Barbara Rehermann
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Authors:  J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

View more
  13 in total

1.  H1N1pdm09 Influenza Virus and Its Descendants Lack Extra-epitopic Amino Acid Residues Associated With Reduced Recognition by M158-66-Specific CD8+ T Cells.

Authors:  Carolien E van de Sandt; Kyung A Sagong; Mark R Pronk; Theo M Bestebroer; Monique I Spronken; Marion P G Koopmans; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

2.  Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.

Authors:  Arwen F Altenburg; Carolien E van de Sandt; Stella E van Trierum; Heidi L M De Gruyter; Peter R W A van Run; Ron A M Fouchier; Kenny Roose; Xavier Saelens; Asisa Volz; Gerd Sutter; Rory D de Vries; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

3.  Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M158-66 Epitope-Specific CD8+ T Lymphocytes.

Authors:  Carolien E van de Sandt; Mark R Pronk; Carel A van Baalen; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

4.  Influenza A surface glycosylation and vaccine design.

Authors:  Chung-Yi Wu; Chih-Wei Lin; Tsung-I Tsai; Chang-Chun David Lee; Hong-Yang Chuang; Jhih-Bin Chen; Ming-Hung Tsai; Bo-Rui Chen; Pei-Wen Lo; Chiu-Ping Liu; Vidya S Shivatare; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-27       Impact factor: 11.205

5.  Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8+ T memory cells in convalescent COVID-19 donors.

Authors:  Jet van den Dijssel; Ruth R Hagen; Rivka de Jongh; Maurice Steenhuis; Theo Rispens; Dionne M Geerdes; Juk Yee Mok; Angela Hm Kragten; Mariël C Duurland; Niels Jm Verstegen; S Marieke van Ham; Wim Je van Esch; Klaas Pjm van Gisbergen; Pleun Hombrink; Anja Ten Brinke; Carolien E van de Sandt
Journal:  Clin Transl Immunology       Date:  2022-10-14

6.  A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.

Authors:  Sergio M Quiñones-Parra; E Bridie Clemens; Zhongfang Wang; Hayley A Croom; Lukasz Kedzierski; Jodie McVernon; Dhanasekaran Vijaykrishna; Katherine Kedzierska
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

Review 7.  Evolution of Influenza A Virus by Mutation and Re-Assortment.

Authors:  Wenhan Shao; Xinxin Li; Mohsan Ullah Goraya; Song Wang; Ji-Long Chen
Journal:  Int J Mol Sci       Date:  2017-08-07       Impact factor: 5.923

8.  Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections.

Authors:  Zeb R Zacharias; Kathleen A Ross; Emma E Hornick; Jonathan T Goodman; Balaji Narasimhan; Thomas J Waldschmidt; Kevin L Legge
Journal:  Front Immunol       Date:  2018-08-28       Impact factor: 7.561

Review 9.  Back to the Future: Lessons Learned From the 1918 Influenza Pandemic.

Authors:  Kirsty R Short; Katherine Kedzierska; Carolien E van de Sandt
Journal:  Front Cell Infect Microbiol       Date:  2018-10-08       Impact factor: 5.293

Review 10.  Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.

Authors:  E Bridie Clemens; Carolien van de Sandt; Sook San Wong; Linda M Wakim; Sophie A Valkenburg
Journal:  Vaccines (Basel)       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.